Image of three people in scrubs looking at a computer screen with a blue hash pattern overlay

Research Grants

Abiomed funds research programs that investigate how mechanical circulatory support with Impella® heart pumps may improve patient outcomes.

Overview

Recovering hearts and saving lives is core to Abiomed’s mission. Our research grants program enables researchers to pioneer innovation in heart recovery. Through novel and groundbreaking research, the scientific community can provide critical insights and uncover solutions that translate to patient care. Abiomed funds innovative research proposals from qualified investigators to advance clinical knowledge and welcomes all research proposals related to heart recovery, with prioritization of our specific areas of interest.

Investigator Responsibilities & Expectations

Applicants awarded funding by Abiomed’s research grants program fulfill the role of the study sponsor and investigator. Abiomed fulfills the role of primary funding source. Funded sponsor-investigators are responsible for the design, management and conduct of the study, as well as maintaining compliance with all applicable laws and regulations. Abiomed and the sponsor-investigators will generate study-specific, progress-based milestones to align expectations and ensure timely execution of the study. 

All types of research programs will be considered, including, but not limited to: clinical studies and pre-clinical investigations. Research programs must focus on how Impella support may improve patient outcomes. Research proposals are reviewed quarterly. Specific areas of interest, instructions for grant submission, and quarterly submission deadlines are outlined below.

Instructions for Grant Submission:

Please review the questions below for guidance on which of our funding mechanisms is right for you.

  1. Does the research require the randomization of human subjects?
  2. Does the research require an investigational device exemption (IDE)?
  3. Does the research program require the involvement of a regulatory body (i.e., FDA, EMA)?
    • If only an IRB or ethics committee is involved, please answer 'no' to this question.

 

If you answer "Yes" to any of the
questions above:

Click Here

 

If you answer "No" to all three questions:

Click Here

NPS-1571